183 related articles for article (PubMed ID: 21566232)
1. Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial.
Shuaib A; Bornstein NM; Diener HC; Dillon W; Fisher M; Hammer MD; Molina CA; Rutledge JN; Saver JL; Schellinger PD; Shownkeen H;
Stroke; 2011 Jun; 42(6):1680-90. PubMed ID: 21566232
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of NeuroFlo device in treatment of patients with atrial fibrillation.
Bernardini GL; Schellinger PD; Abou-Chebl A; Cockroft K; Shuaib A; Sheorajpanday R; Sen S; Diener HC; Leker RR; Bornstein NM
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1457-61. PubMed ID: 24529600
[TBL] [Abstract][Full Text] [Related]
3. Favorable vascular profile is an independent predictor of outcome: a post hoc analysis of the safety and efficacy of NeuroFlo Technology in Ischemic Stroke trial.
Schellinger PD; Köhrmann M; Liu S; Dillon WP; Nogueira RG; Shuaib A; Liebeskind DS;
Stroke; 2013 Jun; 44(6):1606-8. PubMed ID: 23549132
[TBL] [Abstract][Full Text] [Related]
4. Interim report of the SENTIS trial: cerebral perfusion augmentation via partial aortic occlusion in acute ischemic stroke.
Uflacker R; Schönholz C; Papamitisakis N;
J Cardiovasc Surg (Torino); 2008 Dec; 49(6):715-21. PubMed ID: 19043384
[TBL] [Abstract][Full Text] [Related]
5. Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients.
Hammer MD; Schwamm L; Starkman S; Schellinger PD; Jovin T; Nogueira R; Burgin WS; Sen S; Diener HC; Watson T; Michel P; Shuaib A; Dillon W; Liebeskind DS
Int J Stroke; 2012 Dec; 7(8):655-61. PubMed ID: 22264202
[TBL] [Abstract][Full Text] [Related]
6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
7. Reduced mortality and severe disability rates in the SENTIS trial.
Schellinger PD; Shuaib A; Köhrmann M; Liebeskind DS; Jovin T; Hammer MD; Sen S; Huang DY; Solander S; Gupta R; Leker RR; Saver JL;
AJNR Am J Neuroradiol; 2013 Dec; 34(12):2312-6. PubMed ID: 23828106
[TBL] [Abstract][Full Text] [Related]
8. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and Safety of Using External Counterpulsation to Augment Cerebral Blood Flow in Acute Ischemic Stroke-The Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial.
Guluma KZ; Liebeskind DS; Raman R; Rapp KS; Ernstrom KB; Alexandrov AV; Shahripour RB; Barlinn K; Starkman S; Grunberg ID; Hemmen TM; Meyer BC; Alexandrov AW
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2596-604. PubMed ID: 26347398
[TBL] [Abstract][Full Text] [Related]
10. Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke).
von Kummer R; Mori E; Truelsen T; Jensen JS; Grønning BA; Fiebach JB; Lovblad KO; Pedraza S; Romero JM; Chabriat H; Chang KC; Dávalos A; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A; Albers GW;
Stroke; 2016 Dec; 47(12):2880-2887. PubMed ID: 27803391
[TBL] [Abstract][Full Text] [Related]
11. CLOTBUST-Hands Free: pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke.
Barreto AD; Alexandrov AV; Shen L; Sisson A; Bursaw AW; Sahota P; Peng H; Ardjomand-Hessabi M; Pandurengan R; Rahbar MH; Barlinn K; Indupuru H; Gonzales NR; Savitz SI; Grotta JC
Stroke; 2013 Dec; 44(12):3376-81. PubMed ID: 24159060
[TBL] [Abstract][Full Text] [Related]
12. NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset.
Zivin JA; Sehra R; Shoshoo A; Albers GW; Bornstein NM; Dahlof B; Kasner SE; Howard G; Shuaib A; Streeter J; Richieri SP; Hacke W;
Int J Stroke; 2014 Oct; 9(7):950-5. PubMed ID: 23013107
[TBL] [Abstract][Full Text] [Related]
13. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of transcranial laser therapy for acute ischemic stroke.
Zivin JA; Albers GW; Bornstein N; Chippendale T; Dahlof B; Devlin T; Fisher M; Hacke W; Holt W; Ilic S; Kasner S; Lew R; Nash M; Perez J; Rymer M; Schellinger P; Schneider D; Schwab S; Veltkamp R; Walker M; Streeter J;
Stroke; 2009 Apr; 40(4):1359-64. PubMed ID: 19233936
[TBL] [Abstract][Full Text] [Related]
15. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
[TBL] [Abstract][Full Text] [Related]
16. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
[TBL] [Abstract][Full Text] [Related]
17. Randomized assessment of rapid endovascular treatment of ischemic stroke.
Goyal M; Demchuk AM; Menon BK; Eesa M; Rempel JL; Thornton J; Roy D; Jovin TG; Willinsky RA; Sapkota BL; Dowlatshahi D; Frei DF; Kamal NR; Montanera WJ; Poppe AY; Ryckborst KJ; Silver FL; Shuaib A; Tampieri D; Williams D; Bang OY; Baxter BW; Burns PA; Choe H; Heo JH; Holmstedt CA; Jankowitz B; Kelly M; Linares G; Mandzia JL; Shankar J; Sohn SI; Swartz RH; Barber PA; Coutts SB; Smith EE; Morrish WF; Weill A; Subramaniam S; Mitha AP; Wong JH; Lowerison MW; Sajobi TT; Hill MD;
N Engl J Med; 2015 Mar; 372(11):1019-30. PubMed ID: 25671798
[TBL] [Abstract][Full Text] [Related]
18. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
[TBL] [Abstract][Full Text] [Related]
19. Thrombectomy in patients ineligible for iv tPA (THRILL).
Bendszus M; Thomalla G; Knauth M; Hacke W; Bonekamp S; Fiehler J
Int J Stroke; 2015 Aug; 10(6):950-5. PubMed ID: 26044962
[TBL] [Abstract][Full Text] [Related]
20. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
